These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 29025286)
1. [Thalidomide therapy in relapsed diffuse large B-cell lymphoma in elderly patients. Three cases]. Wohner N; Varga G; Szloboda P; Farkas P; Masszi A; Horváth L; Szombath G; Várkonyi J; Benedek S; Masszi T Orv Hetil; 2017 Oct; 158(41):1642-1648. PubMed ID: 29025286 [TBL] [Abstract][Full Text] [Related]
2. Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Is It a Valid Treatment Option? Mondello P; Steiner N; Willenbacher W; Ferrero S; Ghione P; Marabese A; Pitini V; Cuzzocrea S; Mian M Oncologist; 2016 Sep; 21(9):1107-12. PubMed ID: 27382029 [TBL] [Abstract][Full Text] [Related]
3. Higher response to lenalidomide in relapsed/refractory diffuse large B-cell lymphoma in nongerminal center B-cell-like than in germinal center B-cell-like phenotype. Hernandez-Ilizaliturri FJ; Deeb G; Zinzani PL; Pileri SA; Malik F; Macon WR; Goy A; Witzig TE; Czuczman MS Cancer; 2011 Nov; 117(22):5058-66. PubMed ID: 21495023 [TBL] [Abstract][Full Text] [Related]
4. Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial. Zinzani PL; Pellegrini C; Gandolfi L; Stefoni V; Quirini F; Derenzini E; Broccoli A; Argnani L; Pileri S; Baccarani M Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):462-6. PubMed ID: 21859554 [TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy of the combination of lenalidomide and rituximab in elderly relapsed/refractory diffuse large B-cell lymphoma patients. Zinzani PL; Pellegrini C; Derenzini E; Argnani L; Pileri S Hematol Oncol; 2013 Dec; 31(4):223-4. PubMed ID: 23620452 [No Abstract] [Full Text] [Related]
11. Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review. Camicia R; Winkler HC; Hassa PO Mol Cancer; 2015 Dec; 14():207. PubMed ID: 26654227 [TBL] [Abstract][Full Text] [Related]
12. Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study. Nowakowski GS; LaPlant B; Macon WR; Reeder CB; Foran JM; Nelson GD; Thompson CA; Rivera CE; Inwards DJ; Micallef IN; Johnston PB; Porrata LF; Ansell SM; Gascoyne RD; Habermann TM; Witzig TE J Clin Oncol; 2015 Jan; 33(3):251-7. PubMed ID: 25135992 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis. Ghesquières H; Berger F; Felman P; Callet-Bauchu E; Bryon PA; Traverse-Glehen A; Thieblemont C; Baseggio L; Michallet AS; Coiffier B; Salles G J Clin Oncol; 2006 Nov; 24(33):5234-41. PubMed ID: 17043351 [TBL] [Abstract][Full Text] [Related]
15. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma]. Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686 [TBL] [Abstract][Full Text] [Related]
16. Diffuse aggressive lymphoma. Fisher RI; Miller TP; O'Connor OA Hematology Am Soc Hematol Educ Program; 2004; ():221-36. PubMed ID: 15561685 [TBL] [Abstract][Full Text] [Related]
17. A phase I study of bendamustine, lenalidomide and rituximab in relapsed and refractory lymphomas. Cheson BD; Crawford J Br J Haematol; 2015 May; 169(4):528-33. PubMed ID: 25752751 [TBL] [Abstract][Full Text] [Related]
18. Diffuse large B-cell lymphoma. Martelli M; Ferreri AJ; Agostinelli C; Di Rocco A; Pfreundschuh M; Pileri SA Crit Rev Oncol Hematol; 2013 Aug; 87(2):146-71. PubMed ID: 23375551 [TBL] [Abstract][Full Text] [Related]
19. Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy. Mappa S; Marturano E; Licata G; Frezzato M; Frungillo N; Ilariucci F; Stelitano C; Ferrari A; Sorarù M; Vianello F; Baldini L; Proserpio I; Foppoli M; Assanelli A; Reni M; Caligaris-Cappio F; Ferreri AJ Hematol Oncol; 2013 Sep; 31(3):143-50. PubMed ID: 23161567 [TBL] [Abstract][Full Text] [Related]
20. The emerging role of lenalidomide in the management of mantle cell lymphoma (MCL). Dawar R; Hernandez-Ilizaliturri F Best Pract Res Clin Haematol; 2012 Jun; 25(2):185-90. PubMed ID: 22687454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]